Max Robotics — Global Service Robot Directory + US Certification

About

David Schultz is a leading figure in bioinspired robotics and drug delivery, whose work reimagines how therapeutics are administered through the gastrointestinal tract. His research sits at the intersection of soft robotics, biomimicry, and medical device engineering, with a focus on developing ingestible robotic systems that can safely and effectively deliver biomacromolecule therapies. Schultz’s most notable contribution is the design of cephalopod-inspired jetting devices, which mimic the propulsion mechanisms of squid and octopuses to enable needle-free, targeted drug delivery within the GI tract. This breakthrough, detailed in his 2024 paper that has already garnered 52 citations, addresses critical limitations of traditional needle-based injections—such as the need for training, sharps disposal, and patient discomfort—while expanding the potential for oral administration of biologics. By integrating principles from animal locomotion with advanced materials and microfluidics, Schultz has opened new pathways for ingestible robotic devices that could transform the treatment of chronic diseases. His work exemplifies how nature-inspired engineering can solve pressing clinical challenges, earning him recognition as a pioneer in the emerging field of biohybrid drug delivery systems.